The Respicon has been introduced as a sampler for health related measurements of airborne contaminants at workplaces. The instrument is aimed at simultaneous collection of three health related aerosol fractions: (a) the coarser inhalable fraction, defining the aerosol fraction that may enter the nose and mouth during breathing; (b) the intermediate thoracic fraction, defining the fraction that may penetrate beyond the larynx and so reach the lung; and (c) the finer respirable fraction, defining the fraction that may penetrate to gas exchange region of the lung. The instrument has a number of features attractive to occupational hygienists: in addition to providing the three aerosol fractions simultaneously, it is light and compact enough to be used as a personal sampler. yet can be a tripod mounted for area sampling, it can provide samples not only for gravimetric analysis but also microscopic and chemical analyses; and it is also available in a photometric direct-reading version. The instrument has previously been evaluated as an area sampler and, in this mode of operation, has shown reasonable accuracy in collecting respirable, thoracic and inhalable particles, the latter up to particle diameters of ca. 80 microm. Except for some scattered unpublished data there exist no systematic investigations in the Respicon's performance when used as a personal sampler in the industrial environment. In this paper, we will report on a study of side by side comparison of the Respicon with the IOM inhalable sampler, regarded as a reference instrument for the inhalable fraction. The main study was performed at six different workplaces in a nickel refinery. Statistical analysis of the gravimetrically-determined concentration data reveals consistently lower aerosol exposure values for the Respicon as compared to the IOM sampler. The data for the nickel workplaces are compared with findings from other studies. The results are interpreted in the light of the overall results and the possibility of introducing a correction factor is discussed.
ObjectivesChronic obstructive pulmonary disease and silicosis are associated with exposure to crystalline silica. We determined the exposure to respirable crystalline silica and estimated exposure–response relationships between cumulative exposure and pulmonary function in outdoor rock drillers.Methods136 rock drillers and 48 referents were recruited from three heavy construction companies. 98 air samples were collected by personal sampling for determination of respirable particulate matter and crystalline silica. Information about individual job tasks, type of drilling equipment and years of exposure in different job categories was obtained by interview. Cumulative exposure to crystalline silica was calculated for all workers. Pulmonary function was assessed by spirometry. A subgroup of 39 subjects with high cumulative exposure to crystalline silica underwent high-resolution computed tomography (HRCT).ResultsCumulative exposure (mean (min–max)) to crystalline silica was 0.69 mg٠years m–3 (0.01–5.89) in the exposed group. Mean time of exposure among rock drillers was 10.7 years (1–42). Compared with referents, the rock drillers had a lower forced expiratory volume in one second/forced vital capacity ratio (79.4 vs 81.4, p<0.05) and maximal mid-expiratory flow% (85.6 vs 93.9, p<0.05). Further, by stratifying the exposed workers into three equally large groups, a dose–response relationship was demonstrated in the highest exposed group, also in never smokers, at a mean cumulative exposure of 21.7 years at 0.08 mg٠m–3/years. Silicosis was not detected in HRCT, but other patterns of fibrosis and emphysema were seen.ConclusionsOutdoor rock drillers exposed to crystalline silica had significantly lower pulmonary function than referents, and signs of airflow obstruction. Silicosis was not detected.
Intersampler field comparison of Respicon(®), 25-mm closed-face 'total dust' cassette (CFC), and IOM inhalable aerosol sampler was conducted in pot rooms at seven aluminium smelters. The aerosol mass and water-soluble fluoride were selected as airborne contaminants for the comparisons. The aerosol masses of 889 sample pairs of IOM and Respicon(®) inhalable aerosol sub-fraction, 165 of IOM and 25-mm CFC, and 194 of CFC and Respicon(®) thoracic aerosol sub-fraction were compared. The number of sample pairs for the comparison of water-soluble fluoride was 906, 170, and 195, respectively. The geometric mean aerosol mass collected with the inhalable Respicon(®) was 2.91 mg m(-3) compared with 3.38 mg m(-3) with the IOM. The overall ratio between IOM and Respicon(®) inhalable sub-fraction was 1.16 [95% confidence interval (CI) = 1.11-1.21] for aerosol mass and 1.13 (95% CI = 1.08-1.18) for water-soluble fluoride. The results indicate that Respicon(®) undersampled the aerosol mass and water-soluble fluoride in the inhalable sub-fraction compared with the IOM. The results indicated undersampling of the Respicon(®) at mass concentrations higher than 1.35 mg m(-3) and oversampling at lower mass concentrations. The overall ratio between aerosol mass collected with IOM and CFC was 4.19 (95% CI = 3.79-4.64) and 1.61 (95% CI = 1.51-1.72) for water-soluble fluoride. Thus, for this industry, a correction factor of 4.2 is suggested for the conversion of CFC to inhalable aerosol masses and a conversion factor of 1.6 for water-soluble fluoride if wall deposits in the CFC are included. CFC and thoracic Respicon(®) collected similar aerosol masses (ratio = 1.04; 95% CI = 0.97-1.12), whereas the ratio was 1.19 (95% CI = 1.11-1.28) for water-soluble fluoride. The variability of the exposure is substantial; thus, large data sets are required in sampler performance field comparisons.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.